Latest filing published 13 Jan 2026 for Praxis Precision Medicines, Inc., €224k.
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Timothy Edwin Kelly in Praxis Precision Medicines, Inc., where the filings describe the role as finance chief. Between 31 August 2021 and 12 January 2026, the trades on record add up to 22 filings.
On the market, this insider has only ever bought: 4 purchases, €94k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 18 share grants.
A typical purchase (the median) is worth €12k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 13 January 2026 with a share grant (€224k) in Praxis Precision Medicines, Inc. The clock since the last published purchase (6 April 2023) now reads 1,297 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations